EATG » News

Civil society welcomes European Parliament push for a more ambitious EU health budget in 2021-2027

The EU Civil Society Forum on HIV/AIDS, tuberculosis (TB) and viral hepatitis and the Civil Society Forum on Drugs are encouraged to note that the European Parliament has improved the Commission…

A reflection paper dangerously lacking reflection on reaching the agreed target of HIV, viral hepatitis and TB elimination by 2030

Today, the EU Civil Society Forum on HIV/AIDS, tuberculosis and viral hepatitis issues a statement in response to European Commission's reflection paper Towards a Sustainable Europe by 2030. The paper…

The EATG endorses Life4me+ organisation and app

The European AIDS Treatment Group and Life4me.plus to fight AIDS, Hepatitis C and Tuberculosis have agreed to a mutual endorsement as partners.   Life4me+ is a community-based non-profit organisation, which…

The European AIDS Treatment Group names new Executive Director

The European AIDS Treatment Group (EATG) is delighted to introduce our new Executive Director, Pieter Vanholder. Pieter has a background in human rights and law and over a decade of…

#EU4Health: An overarching EU SDG implementation strategy is the only viable scenario

The European AIDS Treatment Group has co-signed a reaction letter to the European Commission’s Reflection Paper: Towards a Sustainable Europe by 2030, together with organisations that have endorsed the #EU4Health…

The EATG urges the Romanian government to adopt and implement the 2019-2021 HIV/AIDS National Strategic Plan

BRUSSELS - Today the European AIDS Treatment Group addresses a letter to the Romanian government in view of the new HIV/AIDS National Strategic Plan. In support of the demands and…

ОТЧЕТ ПО ДОСТУПУ К УСЛУГАМ, ОКАЗЫВАЕМЫМ ПРИ ВИРУСНОМ ГЕПАТИТЕ С, В МЕСТАХ ЛИШЕНИЯ СВОБОДЫ В ЕВРОПЕ ТЕПЕРЬ ЕСТЬ И НА РУССКОМ ЯЗЫКЕ – The report on access to HCV-related services in prison settings in Europe is now available in Russian

Отчет по доступу к услугам, оказываемым при вирусном гепатите С, в местах лишения свободы в Европе теперь есть и на русском языке. Несколько месяцев назад EATG опубликовала этот отчет и…

HepHIV2019: Meeting on implementing HIV, HBV and HCV testing guidance in the real world

In the frame of the HepHIV2019 conference taking place next week in Bucharest (28-30 January), the European AIDS Treatment Group and EuroTEST (formerly HIV in Europe) are co-hosting a multi-stakeholder breakfast…

Call for applications: Continuous Patient Education (CoPE) new call opens

We are pleased to announce that a call for applications for CoPE is now open. Please find below detailed information on how to apply for this grant. The submission deadline is 11…

The EATG publishes its position paper on sex work policy

Today, on the occasion of the International Day to End Violence Against Sex Workers, the European AIDS Treatment Group publishes its stand on the sex work policy debate and approaches…

Vieillir avec le VIH: Brussels-based organisations met to discuss about ageing with HIV

This week the European AIDS Treatment Group participated in a meeting on “Ageing with HIV: What challenges? What ways forward?”, organised by two francophone organisations based in Brussels that work…

The European AIDS Treatment Group supports the petition towards the next Global Fund Replenishment Conference

Ahead of the next conference to replenish the Global Fund in October 2019 in France, AIDES -together with collaborating organisations (Action Santé Mondiale / Global Health Advocates, Coalition PLUS, Équilibres & Populations, Médecins du…

Reporting from the 2nd Hep-C Community Summit (Lisbon, 18 September 2018)

The Hep-C Community Summit, organised by Correlation European Harm Reduction Network, has brought together people from the affected communities, advocates, researchers, healthcare providers, harm reduction practitioners, and policymakers to discuss…

EHVA: European HIV advocates discuss about new clinical study aiming to evaluate experimental strategies for the control of HIV infection

On Thursday, 15th of November, the European AIDS Treatment Group hosted a meeting with members of HIV organisations from six European countries to discuss the launch of the study EHVA…

HIV Outcomes: Online Compendium of Good Practices for the long-term health of people living with HIV launched

BRUSSELS: Today, HIV Outcomes launched an Online Compendium of Good Practices for securing the long-term health and well-being of people living with HIV.   Although people with HIV can now anticipate…

EmERGE: Community Meeting for the Last Phase of the Project (Madrid – November 7 2018)

The EmERGE project (about developing a mHealth platform for self-management of HIV and reducing face-to-face consultations), funded by the European Commission, has started its last 18 months. The European AIDS…

14 Patient Organisations Call for Meaningful Involvement in European Cooperation on Health Technology Assessment (HTA)

Today, 14 European patient organisations & federations have launched a statement calling on European institutions to adopt appropriate measures to fully incorporate meaningful involvement of patients in EU cooperation on…

The EATG publishes its position paper on drugs policy

Today, on the occasion of the joint meeting of the EU Civil Society Forum on HIV, Hepatitis and TB and the EU Civil Society Forum on Drugs, the European AIDS…

The EATG in the Civil Society Fora joint meetings (Brussels 6-8 November)

From 6-8 November, the EATG will be actively engaged in developing joint advocacy, sharing with and learning from civil society partners across Europe within the EU Civil Society Forum  on…

HIV Drug Therapy 2018 Congress – Quality of Life Across Different Age Groups of People Living with HIV: A Community Perspective

The European AIDS Treatment Group had the opportunity to co-organise and co-chair the ‘Quality of Life Across Different Age Groups of PLHIV: A Community Perspective’ session during this year's HIV Drug Therapy…

Landmark international guidelines launched on human rights and drug policy

VIENNA/GENEVA, 15 March 2019—A coalition of United Nations Member States, United Nations entities and leading human rights experts meeting at the Commission on Narcotic Drugs in Vienna, Austria, today launched…

People who use drugs: still being left behind

While the incidence of HIV infection globally for all ages declined by 22% between 2011 and 2017, HIV infections among people who inject drugs appear to be rising. HIV incidence—the…

Healthcare providers should discuss U=U with all their HIV-positive patients

Healthcare providers should inform all patients with HIV they cannot transmit HIV to a sexual partner when their viral load is undetectable, argue the authors of  a strongly worded comment…

Q&A: Understanding persistent low-level viremia in people with HIV

Persistent low-level viremia among people living with HIV who are adhering to treatment is a challenging issue for clinicians, and there is not much guidance available. In a 2017 blog…

Curing HIV just got more complicated. Can CRISPR help?

SEATTLE, WASHINGTON — Antiretroviral (ARV) drugs have turned HIV infection from a death sentence to a chronic condition. In most people the drugs routinely tamp HIV levels so low that…

CytoDyn submits first part of biologics license application to FDA for leronlimab (PRO 140)

CytoDyn reaches historical milestone, submits first of three sections of BLA to FDA for leronlimab (PRO 140) as a combination therapy for HIV -- FDA previously granted Rolling Review for…

What is the real link between bacterial vaginosis and HIV risk in women?

New Rochelle, NY, March 15, 2019--An international team of researchers presents a comprehensive and renewed focus on the common, yet poorly understood condition of bacterial vaginosis (BV) and how the…

US: 80% of new HIV cases transmitted by undiagnosed or untreated people

In 2016, more than 80% of new HIV infections in the United States were transmitted by individuals who either did not know they were infected with HIV or had been…

CROI 2019: Hepatitis C treatment reduces risk of diabetes

Treatment of hepatitis C virus (HCV) infection is associated with better glucose control and a lower likelihood of developing diabetes, according to a report at the Conference on Retroviruses and…

Daily aspirin may reduce HBV-related hepatocellular carcinoma risk

The risk for hepatocellular carcinoma was statistically significantly reduced by 29% in patients with hepatitis B virus who received daily aspirin, according to findings published in JAMA Internal Medicine. “Antiviral therapy cannot erase…

Business as usual for governments at the UN as drugs hit record levels

14 March 2019, VIENNA – The International Drug Policy Consortium expresses disappointment following the UN’s adoption of a 10-year global drug strategy that fails to deal with the realities and the devastating…

Large national survey shows smaller HIV epidemic in Nigeria than once thought

Highlights key gaps toward reaching HIV epidemic control Washington, DC (March 14, 2019) — The Government of Nigeria released new data today from the Nigeria HIV/AIDS Indicator and Impact Survey…

HCV, HBV viral control improves kidney transplant survival rates

Kidney transplant recipients with hepatitis B and hepatitis C in whom viral replication was controlled had similar overall and graft survival rates as patients without viral hepatitis, according to data…

Individualized lifestyle intervention may reduce type 2 diabetes risk in HIV

For adults with HIV, a lifestyle intervention focused on energy restriction, weight reduction and improved diet may be an effective way to decrease type 2 diabetes risk, according to findings…

UNAIDS report: Health, rights and drugs: harm reduction, decriminalization and zero discrimination for PWUD

Promises to improve health outcomes for people who inject drugs remain unfulfilled as 99% do not have adequate access to HIV and harm reduction services -- New report by UNAIDS…

TAG statement on the President’s FY 2020 budget proposal

Treatment Action Group (TAG) opposes the President's Fiscal Year (FY) 2020 budget proposal, which makes a mockery of the administration's purported strategy to end AIDS in the United States over…

Attack on Athens Checkpoint

On Monday, March 11, there was an arson attack in the premises of Athens Checkpoint - the most prominent community-based HIV testing and counseling facility in Greece, offering free services…

Hepatitis B vaccination in preadolescents lowered the disease incidence rate in Catalonia

Introducing Hepatitis B vaccine in preadolescents meant a decline in the disease incidence rate by 52 % according to a study in which the University of Barcelona (UB) took part.…

HIV i-Base: HTB, first reports from CROI 2019; Fit for Purpose report 2019 released

HIV Treatment Bulletin (HTB) is a community publication produced by HIV i-Base. This edition of HTB includes the first reports from CROI 2019, with additional reports following in subsequent issues.…

CROI 2019: Dolutegravir-based second-line ART achieves excellent virological outcomes even in the presence of resistance to recycled NRTIs

Virological response rates were excellent among patients receiving second-line antiretroviral therapy (ART) based on dolutegravir, even when regimens included a nucleoside/nucleotide reverse transcriptase inhibitor (NRTI) to which there was pre-existing…